Liquid Biopsy Market by Cancer Type (Lung Cancer, Pancreatic Cancer, Leukemia and Other Visceral Cancers) by Sample Type (Blood, Urine, Plasma, Saliva and Cerebrospinal) by Diagnostic Approach (Circulating Tumour cells (CTC), Circulating Tumour DNA (ctDNA), RNA in exosomes and Extra-Cellular Vesicles), By End Users (Reference Laboratories, Hospital/Physician Laboratories, Academic and Research Centers, and Other End Users) and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Liquid Biopsy Market by Cancer Type (Lung Cancer, Pancreatic Cancer, Leukemia and Other Visceral Cancers) by Sample Type (Blood, Urine, Plasma, Saliva and Cerebrospinal) by Diagnostic Approach (Circulating Tumour cells (CTC), Circulating Tumour DNA (ctDNA), RNA in exosomes and Extra-Cellular Vesicles), By End Users (Reference Laboratories, Hospital/Physician Laboratories, Academic and Research Centers, and Other End Users) and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 950 | Pages: 178 | October 2016 | Region: Global


The Global Liquid Biopsy market is expected to increase at a CAGR of 24.3% in the forecast period of 2016-2021 and reach a value of USD 1.75 billion by 2021 from USD 590.2 million in 2016.

This technology of liquid biopsy has enormous diagnostic and treatment implications for oncology and it is believed to transform clinical practice. A liquid biopsy, may capture the entire heterogeneity of the disease. This methodology is advantageous over tissue biopsies as monitoring of tumour genomic can be done by taking serial samples.

Foremost drivers for the liquid biopsy market include. Liquid biopsies are adopted due to the factors such as tolerability and patient convenience. Tissue biopsies cannot be done for few non-small cell lung cancers and liquid biopsy procedures are replacing tissue diagnosis procedures in such cases. Liquid biopsy research process involves a large amount of money and frequent clinical trials which is acting as a restraint for the market growth.

The liquid biopsy market is mainly segmented by types of cancer into Lung Cancer, Pancreatic Cancer, Leukemia and Other Visceral Cancers. By Diagnostic approach they can be classified as Circulating Tumour cells (CTC), Circulating Tumour DNA (ctDNA), RNA in exosomes and Extra-Cellular Vesicles. Based on end users, the market is segmented into reference laboratories, hospital/physician laboratories, academic and research centers, and other end users. The market is bifurcate into blood, urine, plasma, saliva and Cerebrospinal fluid based upon sample type. CTCs (Circulating Tumour cells), the first such entities on the liquid biopsy scene, have accounted for a large share in the market. Cancer institute is the largest end user segment in terms of revenues and is expected to create substantial opportunity in global liquid biopsy market over the forecast period.     

Geographically the market is segmented into North America (U.S.A. and Canada), Europe (U.K., Germany, Italy, France, and Spain), Asia-Pacific (India, China, Australia, South Korea and Japan), Latin America (Mexico, Argentina and Brazil), Middle east and Africa. All major action in the field of liquid biopsy is expected to emerge from North America and Europe region over the forecast period. However, increasing funding for private public partnerships in field of cancer research is expected to fuel the Asia-Pacific Market.

The key players dominating the liquid biopsy market are Janssen Diagnostics, Qiagen, Rarecells SAS, Silicon Biosystems, SRI International, Myriad Genetics, Natera, Personal Genome Diagnostics, Sysmex Inostics, Trovagene, Exosome Diagnostics, Exosome Sciences, and HansaBiomed OU.

1. Introduction                                                 

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                           

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                              

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                            

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                     

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                      

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                      

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                               

5. Market Segmentation                                                              

                5.1 By Cancer Type                                         

                                5.1.1 Lung Cancer                           

                                5.1.2 Pancreatic Cancer                

                                5.1.3 Leukemia                

                                5.1.4 Other Visceral Cancers                       

                5.2 By Sample Type                                        

                                5.2.1 Blood                        

                                5.2.2 Urine                         

                                5.2.3 Plasma                      

                                5.2.4 Saliva                         

                                5.2.5 Cerebrospinal                        

                5.3 By Diagnostic Approach                                        

                                5.3.1 Circulating Tumour cells (CTC)                        

                                5.3.2 Circulating Tumour DNA (ctDNA)                  

                                5.3.3 RNA in exosomes                 

                                5.3.4 Extra-Cellular Vesicles                        

                5.4 By End Users                                             

                                5.4.1 Reference Laboratories                     

                                5.4.2 Hospital/Physician Laboratories                     

                                5.4.3 Academic and Research Centers                    

                                5.4.4 Other End Users                   

6. Geographical Analysis                                                              

                6.1 North America                                          

                                6.1.1 Introduction                           

                                6.1.2 United States                         

                                6.1.3 Canada                     

                6.2 Europe                                         

                                6.2.1 Introduction                           

                                6.2.2 U.K                             

                                6.2.3 Spain                         

                                6.2.4 Germany                 

                                6.2.5 Italy                           

                                6.2.6 France                      

                6.3 Asia-Pacific                                 

                                6.3.1 Introduction                           

                                6.3.2 China                         

                                6.3.3 India                          

                                6.3.4 Japan                        

                                6.3.5 South Korea                           

                                6.3.6 Australia                  

                6.4 Latin America                                            

                                6.4.1 Introduction                           

                                6.4.2 Brazil                         

                                6.4.3 Mexico                     

                                6.4.4 Argentina                

                                6.4.5 Rest of Latin America                         

                6.5 Middle East & Africa                               

                                6.5.1 Introduction                           

                                6.5.2 Middle-East                            

                                6.5.3 Africa                        

7. Strategic Analysis                                                       

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                      

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services               

                                7.2.5 Competitive Rivalry within the Industry                      

8. Market Leaders' Analysis                                                        

                8.1 Janssen Diagnostics                                

                                8.1.1 Overview                

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                            

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Qiagen                                         

                8.3 Rarecells SAS                                             

                8.4 Silicon Biosystems                                   

                8.5 SRI International                                      

                8.6 Myriad Genetics                                      

                8.7 Natera                                          

                8.8 Personal Genome Diagnostics                                            

                8.9 Sysmex Inostics                                        

                8.10 Trovagene                                

                8.11 Exosome Diagnostics                                           

                8.12 HansaBiomed OU                                  

9. Competitive Landscape                                                           

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                        

                9.3 Agreements, collaborations and Joint Ventures                                          

                9.4 New Product Launches                                          

10. Expert Opinions                                                        

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Global Liquid Biopsy Market By Region, From 2016-2021 (USD Million)
  2. Global Liquid Biopsy Market By Cancer Type, From 2016-2021 (USD Million)
  3. Global Lung Cancer Market By Region, From 2016-2021 (USD Million)
  4. Global Pancreatic Cancer Market By Region, From 2016-2021 (USD Million)
  5. Global Leukemia Market By Region, From 2016-2021 (USD Million)
  6. Global Other Visceral Cancers Market By Region, From 2016-2021 (USD Million)
  7. Global Liquid Biopsy Market By Sample Type, From 2016-2021 (USD Million)
  8. Global Blood Market By Region, From 2016-2021 (USD Million)
  9. Global Urine Market By Region, From 2016-2021 (USD Million)
  10. Global Plasma Market By Region, From 2016-2021 (USD Million)
  11. Global Saliva Market By Region, From 2016-2021 (USD Million)
  12. Global Cerebrospinal Market By Region, From 2016-2021 (USD Million)
  13. Global Liquid Biopsy Market By Diagnostic Approach, From 2016-2021 (USD Million)
  14. Global Circulating Tumour cells (CTC) Market By Region, From 2016-2021 (USD Million)
  15. Global Circulating Tumour DNA (ctDNA) Market By Region, From 2016-2021 (USD Million)
  16. Global RNA in exosomes Market By Region, From 2016-2021 (USD Million)
  17. Global Extra-Cellular Vesicles Market By Region, From 2016-2021 (USD Million)
  18. Global Liquid Biopsy Market By End Users, From 2016-2021 (USD Million)
  19. Global Reference Laboratories Market By Region, From 2016-2021 (USD Million)
  20. Global Hospital/Physician Laboratories Market By Region, From 2016-2021 (USD Million)
  21. Global Academic and Research Centers Market By Region, From 2016-2021 (USD Million)
  22. Global Other End Users Market By Region, From 2016-2021 (USD Million)
  23. North America Liquid Biopsy Market By Region, From 2016-2021 (USD Million)
  24. North America Liquid Biopsy Market By Cancer Type, From 2016-2021 (USD Million)
  25. North America Lung Cancer Market By Region, From 2016-2021 (USD Million)
  26. North America Pancreatic Cancer Market By Region, From 2016-2021 (USD Million)
  27. North America Leukemia Market By Region, From 2016-2021 (USD Million)
  28. North America Other Visceral Cancers Market By Region, From 2016-2021 (USD Million)
  29. North America Liquid Biopsy Market By Sample Type, From 2016-2021 (USD Million)
  30. North America Blood Market By Region, From 2016-2021 (USD Million)
  31. North America Urine Market By Region, From 2016-2021 (USD Million)
  32. North America Plasma Market By Region, From 2016-2021 (USD Million)
  33. North America Saliva Market By Region, From 2016-2021 (USD Million)
  34. North America Cerebrospinal Market By Region, From 2016-2021 (USD Million)
  35. North America Liquid Biopsy Market By Diagnostic Approach, From 2016-2021 (USD Million)
  36. North America Circulating Tumour cells (CTC) Market By Region, From 2016-2021 (USD Million)
  37. North America Circulating Tumour DNA (ctDNA) Market By Region, From 2016-2021 (USD Million)
  38. North America RNA in exosomes Market By Region, From 2016-2021 (USD Million)
  39. North America Extra-Cellular Vesicles Market By Region, From 2016-2021 (USD Million)
  40. North America Liquid Biopsy Market By End Users, From 2016-2021 (USD Million)
  41. North America Reference Laboratories Market By Region, From 2016-2021 (USD Million)
  42. North America Hospital/Physician Laboratories Market By Region, From 2016-2021 (USD Million)
  43. North America Academic and Research Centers Market By Region, From 2016-2021 (USD Million)
  44. North America Other End Users Market By Region, From 2016-2021 (USD Million)
  45. United States Liquid Biopsy Market By Cancer Type, From 2016-2021 (USD Million)
  46. United States Liquid Biopsy Market By Sample Type, From 2016-2021 (USD Million)
  47. United States Liquid Biopsy Market By Diagnostic Approach, From 2016-2021 (USD Million)
  48. United States Liquid Biopsy Market By End Users, From 2016-2021 (USD Million)
  49. Canada Liquid Biopsy Market By Cancer Type, From 2016-2021 (USD Million)
  50. Canada Liquid Biopsy Market By Sample Type, From 2016-2021 (USD Million)
  51. Canada Liquid Biopsy Market By Diagnostic Approach, From 2016-2021 (USD Million)
  52. Canada Liquid Biopsy Market By End Users, From 2016-2021 (USD Million)
  53. Europe Liquid Biopsy Market By Region, From 2016-2021 (USD Million)
  54. Europe Liquid Biopsy Market By Cancer Type, From 2016-2021 (USD Million)
  55. Europe Lung Cancer Market By Region, From 2016-2021 (USD Million)
  56. Europe Pancreatic Cancer Market By Region, From 2016-2021 (USD Million)
  57. Europe Leukemia Market By Region, From 2016-2021 (USD Million)
  58. Europe Other Visceral Cancers Market By Region, From 2016-2021 (USD Million)
  59. Europe Liquid Biopsy Market By Sample Type, From 2016-2021 (USD Million)
  60. Europe Blood Market By Region, From 2016-2021 (USD Million)
  61. Europe Urine Market By Region, From 2016-2021 (USD Million)
  62. Europe Plasma Market By Region, From 2016-2021 (USD Million)
  63. Europe Saliva Market By Region, From 2016-2021 (USD Million)
  64. Europe Cerebrospinal Market By Region, From 2016-2021 (USD Million)
  65. Europe Liquid Biopsy Market By Diagnostic Approach, From 2016-2021 (USD Million)
  66. Europe Circulating Tumour cells (CTC) Market By Region, From 2016-2021 (USD Million)
  67. Europe Circulating Tumour DNA (ctDNA) Market By Region, From 2016-2021 (USD Million)
  68. Europe RNA in exosomes Market By Region, From 2016-2021 (USD Million)
  69. Europe Extra-Cellular Vesicles Market By Region, From 2016-2021 (USD Million)
  70. Europe Liquid Biopsy Market By End Users, From 2016-2021 (USD Million)
  71. Europe Reference Laboratories Market By Region, From 2016-2021 (USD Million)
  72. Europe Hospital/Physician Laboratories Market By Region, From 2016-2021 (USD Million)
  73. Europe Academic and Research Centers Market By Region, From 2016-2021 (USD Million)
  74. Europe Other End Users Market By Region, From 2016-2021 (USD Million)
  75. U.K Liquid Biopsy Market By Cancer Type, From 2016-2021 (USD Million)
  76. U.K Liquid Biopsy Market By Sample Type, From 2016-2021 (USD Million)
  77. U.K Liquid Biopsy Market By Diagnostic Approach, From 2016-2021 (USD Million)
  78. U.K Liquid Biopsy Market By End Users, From 2016-2021 (USD Million)
  79. Spain Liquid Biopsy Market By Cancer Type, From 2016-2021 (USD Million)
  80. Spain Liquid Biopsy Market By Sample Type, From 2016-2021 (USD Million)
  81. Spain Liquid Biopsy Market By Diagnostic Approach, From 2016-2021 (USD Million)
  82. Spain Liquid Biopsy Market By End Users, From 2016-2021 (USD Million)
  83. Germany Liquid Biopsy Market By Cancer Type, From 2016-2021 (USD Million)
  84. Germany Liquid Biopsy Market By Sample Type, From 2016-2021 (USD Million)
  85. Germany Liquid Biopsy Market By Diagnostic Approach, From 2016-2021 (USD Million)
  86. Germany Liquid Biopsy Market By End Users, From 2016-2021 (USD Million)
  87. Italy Liquid Biopsy Market By Cancer Type, From 2016-2021 (USD Million)
  88. Italy Liquid Biopsy Market By Sample Type, From 2016-2021 (USD Million)
  89. Italy Liquid Biopsy Market By Diagnostic Approach, From 2016-2021 (USD Million)
  90. Italy Liquid Biopsy Market By End Users, From 2016-2021 (USD Million)
  91. France Liquid Biopsy Market By Cancer Type, From 2016-2021 (USD Million)
  92. France Liquid Biopsy Market By Sample Type, From 2016-2021 (USD Million)
  93. France Liquid Biopsy Market By Diagnostic Approach, From 2016-2021 (USD Million)
  94. France Liquid Biopsy Market By End Users, From 2016-2021 (USD Million)
  95. Asia-Pacific Liquid Biopsy Market By Region, From 2016-2021 (USD Million)
  96. Asia-Pacific Liquid Biopsy Market By Cancer Type, From 2016-2021 (USD Million)
  97. Asia-Pacific Lung Cancer Market By Region, From 2016-2021 (USD Million)
  98. Asia-Pacific Pancreatic Cancer Market By Region, From 2016-2021 (USD Million)
  99. Asia-Pacific Leukemia Market By Region, From 2016-2021 (USD Million)
  100. Asia-Pacific Other Visceral Cancers Market By Region, From 2016-2021 (USD Million)
  101. Asia-Pacific Liquid Biopsy Market By Sample Type, From 2016-2021 (USD Million)
  102. Asia-Pacific Blood Market By Region, From 2016-2021 (USD Million)
  103. Asia-Pacific Urine Market By Region, From 2016-2021 (USD Million)
  104. Asia-Pacific Plasma Market By Region, From 2016-2021 (USD Million)
  105. Asia-Pacific Saliva Market By Region, From 2016-2021 (USD Million)
  106. Asia-Pacific Cerebrospinal Market By Region, From 2016-2021 (USD Million)
  107. Asia-Pacific Liquid Biopsy Market By Diagnostic Approach, From 2016-2021 (USD Million)
  108. Asia-Pacific Circulating Tumour cells (CTC) Market By Region, From 2016-2021 (USD Million)
  109. Asia-Pacific Circulating Tumour DNA (ctDNA) Market By Region, From 2016-2021 (USD Million)
  110. Asia-Pacific RNA in exosomes Market By Region, From 2016-2021 (USD Million)
  111. Asia-Pacific Extra-Cellular Vesicles Market By Region, From 2016-2021 (USD Million)
  112. Asia-Pacific Liquid Biopsy Market By End Users, From 2016-2021 (USD Million)
  113. Asia-Pacific Reference Laboratories Market By Region, From 2016-2021 (USD Million)
  114. Asia-Pacific Hospital/Physician Laboratories Market By Region, From 2016-2021 (USD Million)
  115. Asia-Pacific Academic and Research Centers Market By Region, From 2016-2021 (USD Million)
  116. Asia-Pacific Other End Users Market By Region, From 2016-2021 (USD Million)
  117. China Liquid Biopsy Market By Cancer Type, From 2016-2021 (USD Million)
  118. China Liquid Biopsy Market By Sample Type, From 2016-2021 (USD Million)
  119. China Liquid Biopsy Market By Diagnostic Approach, From 2016-2021 (USD Million)
  120. China Liquid Biopsy Market By End Users, From 2016-2021 (USD Million)
  121. India Liquid Biopsy Market By Cancer Type, From 2016-2021 (USD Million)
  122. India Liquid Biopsy Market By Sample Type, From 2016-2021 (USD Million)
  123. India Liquid Biopsy Market By Diagnostic Approach, From 2016-2021 (USD Million)
  124. India Liquid Biopsy Market By End Users, From 2016-2021 (USD Million)
  125. Japan Liquid Biopsy Market By Cancer Type, From 2016-2021 (USD Million)
  126. Japan Liquid Biopsy Market By Sample Type, From 2016-2021 (USD Million)
  127. Japan Liquid Biopsy Market By Diagnostic Approach, From 2016-2021 (USD Million)
  128. Japan Liquid Biopsy Market By End Users, From 2016-2021 (USD Million)
  129. South Korea Liquid Biopsy Market By Cancer Type, From 2016-2021 (USD Million)
  130. South Korea Liquid Biopsy Market By Sample Type, From 2016-2021 (USD Million)
  131. South Korea Liquid Biopsy Market By Diagnostic Approach, From 2016-2021 (USD Million)
  132. South Korea Liquid Biopsy Market By End Users, From 2016-2021 (USD Million)
  133. Australia Liquid Biopsy Market By Cancer Type, From 2016-2021 (USD Million)
  134. Australia Liquid Biopsy Market By Sample Type, From 2016-2021 (USD Million)
  135. Australia Liquid Biopsy Market By Diagnostic Approach, From 2016-2021 (USD Million)
  136. Australia Liquid Biopsy Market By End Users, From 2016-2021 (USD Million)
  137. Latin America Liquid Biopsy Market By Region, From 2016-2021 (USD Million)
  138. Latin America Liquid Biopsy Market By Cancer Type, From 2016-2021 (USD Million)
  139. Latin America Lung Cancer Market By Region, From 2016-2021 (USD Million)
  140. Latin America Pancreatic Cancer Market By Region, From 2016-2021 (USD Million)
  141. Latin America Leukemia Market By Region, From 2016-2021 (USD Million)
  142. Latin America Other Visceral Cancers Market By Region, From 2016-2021 (USD Million)
  143. Latin America Liquid Biopsy Market By Sample Type, From 2016-2021 (USD Million)
  144. Latin America Blood Market By Region, From 2016-2021 (USD Million)
  145. Latin America Urine Market By Region, From 2016-2021 (USD Million)
  146. Latin America Plasma Market By Region, From 2016-2021 (USD Million)
  147. Latin America Saliva Market By Region, From 2016-2021 (USD Million)
  148. Latin America Cerebrospinal Market By Region, From 2016-2021 (USD Million)
  149. Latin America Liquid Biopsy Market By Diagnostic Approach, From 2016-2021 (USD Million)
  150. Latin America Circulating Tumour cells (CTC) Market By Region, From 2016-2021 (USD Million)
  151. Latin America Circulating Tumour DNA (ctDNA) Market By Region, From 2016-2021 (USD Million)
  152. Latin America RNA in exosomes Market By Region, From 2016-2021 (USD Million)
  153. Latin America Extra-Cellular Vesicles Market By Region, From 2016-2021 (USD Million)
  154. Latin America Liquid Biopsy Market By End Users, From 2016-2021 (USD Million)
  155. Latin America Reference Laboratories Market By Region, From 2016-2021 (USD Million)
  156. Latin America Hospital/Physician Laboratories Market By Region, From 2016-2021 (USD Million)
  157. Latin America Academic and Research Centers Market By Region, From 2016-2021 (USD Million)
  158. Latin America Other End Users Market By Region, From 2016-2021 (USD Million)
  159. Brazil Liquid Biopsy Market By Cancer Type, From 2016-2021 (USD Million)
  160. Brazil Liquid Biopsy Market By Sample Type, From 2016-2021 (USD Million)
  161. Brazil Liquid Biopsy Market By Diagnostic Approach, From 2016-2021 (USD Million)
  162. Brazil Liquid Biopsy Market By End Users, From 2016-2021 (USD Million)
  163. Argentina Liquid Biopsy Market By Cancer Type, From 2016-2021 (USD Million)
  164. Argentina Liquid Biopsy Market By Sample Type, From 2016-2021 (USD Million)
  165. Argentina Liquid Biopsy Market By Diagnostic Approach, From 2016-2021 (USD Million)
  166. Argentina Liquid Biopsy Market By End Users, From 2016-2021 (USD Million)
  167. Mexico Liquid Biopsy Market By Cancer Type, From 2016-2021 (USD Million)
  168. Mexico Liquid Biopsy Market By Sample Type, From 2016-2021 (USD Million)
  169. Mexico Liquid Biopsy Market By Diagnostic Approach, From 2016-2021 (USD Million)
  170. Mexico Liquid Biopsy Market By End Users, From 2016-2021 (USD Million)
  171. Middle East & Africa Liquid Biopsy Market By Region, From 2016-2021 (USD Million)
  172. Middle East & Africa Liquid Biopsy Market By Cancer Type, From 2016-2021 (USD Million)
  173. Middle East & Africa Lung Cancer Market By Region, From 2016-2021 (USD Million)
  174. Middle East & Africa Pancreatic Cancer Market By Region, From 2016-2021 (USD Million)
  175. Middle East & Africa Leukemia Market By Region, From 2016-2021 (USD Million)
  176. Middle East & Africa Other Visceral Cancers Market By Region, From 2016-2021 (USD Million)
  177. Middle East & Africa Liquid Biopsy Market By Sample Type, From 2016-2021 (USD Million)
  178. Middle East & Africa Blood Market By Region, From 2016-2021 (USD Million)
  179. Middle East & Africa Urine Market By Region, From 2016-2021 (USD Million)
  180. Middle East & Africa Plasma Market By Region, From 2016-2021 (USD Million)
  181. Middle East & Africa Saliva Market By Region, From 2016-2021 (USD Million)
  182. Middle East & Africa Cerebrospinal Market By Region, From 2016-2021 (USD Million)
  183. Middle East & Africa Liquid Biopsy Market By Diagnostic Approach, From 2016-2021 (USD Million)
  184. Middle East & Africa Circulating Tumour cells (CTC) Market By Region, From 2016-2021 (USD Million)
  185. Middle East & Africa Circulating Tumour DNA (ctDNA) Market By Region, From 2016-2021 (USD Million)
  186. Middle East & Africa RNA in exosomes Market By Region, From 2016-2021 (USD Million)
  187. Middle East & Africa Extra-Cellular Vesicles Market By Region, From 2016-2021 (USD Million)
  188. Middle East & Africa Liquid Biopsy Market By End Users, From 2016-2021 (USD Million)
  189. Middle East & Africa Reference Laboratories Market By Region, From 2016-2021 (USD Million)
  190. Middle East & Africa Hospital/Physician Laboratories Market By Region, From 2016-2021 (USD Million)
  191. Middle East & Africa Academic and Research Centers Market By Region, From 2016-2021 (USD Million)
  192. Middle East & Africa Other End Users Market By Region, From 2016-2021 (USD Million)
  193. Middle East Liquid Biopsy Market By Cancer Type, From 2016-2021 (USD Million)
  194. Middle East Liquid Biopsy Market By Sample Type, From 2016-2021 (USD Million)
  195. Middle East Liquid Biopsy Market By Diagnostic Approach, From 2016-2021 (USD Million)
  196. Middle East Liquid Biopsy Market By End Users, From 2016-2021 (USD Million)
  197. Africa Liquid Biopsy Market By Cancer Type, From 2016-2021 (USD Million)
  198. Africa Liquid Biopsy Market By Sample Type, From 2016-2021 (USD Million)
  199. Africa Liquid Biopsy Market By Diagnostic Approach, From 2016-2021 (USD Million)
  200. Africa Liquid Biopsy Market By End Users, From 2016-2021 (USD Million)
Middle East And Africa Virology Market By Type (Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy, Interferons) By Application (Skin And Soft Tissue Infections, GI Tract Infections, Urinar...
Latin America Virology Market By Type (Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy, Interferons) By Application (Skin And Soft Tissue Infections, GI Tract Infections, Urinary Tract I...
Asia Pacific Virology Market By Type (Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy, Interferons) By Application (Skin And Soft Tissue Infections, GI Tract Infections, Urinary Tract In...
Europe Virology Market By Type (Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy, Interferons) By Application (Skin And Soft Tissue Infections, GI Tract Infections, Urinary Tract Infectio...
North America Virology Market By Type (Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy, Interferons) By Application (Skin And Soft Tissue Infections, GI Tract Infections, Urinary Tract I...
Virology Market By Type (Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy, Interferons) By Application (Skin And Soft Tissue Infections, GI Tract Infections, Urinary Tract Infection, Eye ...
Middle East And Africa Lateral Flow Assay Market By Product (Reader, Kit), Application (Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker), Veterinary, Drug Development, Food Safety), Technique (Competi...
Latin America Lateral Flow Assay Market By Product (Reader, Kit), Application (Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker), Veterinary, Drug Development, Food Safety), Technique (Competitive, Mul...
Asia Pacific Lateral Flow Assay Market By Product (Reader, Kit), Application (Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker), Veterinary, Drug Development, Food Safety), Technique (Competitive, Mult...
Europe Lateral Flow Assay Market By Product (Reader, Kit), Application (Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker), Veterinary, Drug Development, Food Safety), Technique (Competitive, Multiplex,...
North America Lateral Flow Assay Market By Product (Reader, Kit), Application (Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker), Veterinary, Drug Development, Food Safety), Technique (Competitive, Mul...
Lateral Flow Assay Market By Product (Reader, Kit), Application (Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker), Veterinary, Drug Development, Food Safety), Technique (Competitive, Multiplex, Sandwi...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.